CONTROVERSIES IN THE MANAGEMENT OF EARLY-STAGE HODGKINS-DISEASE

被引：55
作者：
MAUCH, PM
机构：
来源：
BLOOD | 1994年 / 83卷 / 02期
关键词：
D O I：
10.1182/blood.V83.2.318.bloodjournal832318
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：318 / 329
页数：12
相关论文
共 151 条
  • [61] THE PLACE OF RADIOTHERAPY IN THE MANAGEMENT OF LOCALIZED HODGKINS-DISEASE .11.
    HOPESTONE, HF
    [J]. CLINICAL RADIOLOGY, 1981, 32 (05) : 519 - 522
  • [62] HOPPE R, 1989, CURRENT STANFORD CLI, P182
  • [63] THE MANAGEMENT OF STAGE-II HODGKINS-DISEASE WITH A LARGE MEDIASTINAL MASS - A PROSPECTIVE PROGRAM EMPHASIZING IRRADIATION
    HOPPE, RT
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (02): : 349 - 355
  • [64] HOPPE RT, 1982, BLOOD, V59, P455
  • [65] VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE
    HORNING, SJ
    HOPPE, RT
    HANCOCK, SL
    ROSENBERG, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) : 1822 - 1831
  • [66] JACQUILLAT C, 1984, CANCER, V53, P459, DOI 10.1002/1097-0142(19840201)53:3<459::AID-CNCR2820530315>3.0.CO
  • [67] 2-V
  • [68] PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL AFTER HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE
    JAGANNATH, S
    ARMITAGE, JO
    DICKE, KA
    TUCKER, SL
    VELASQUEZ, WS
    SMITH, K
    VAUGHAN, WP
    KESSINGER, A
    HORWITZ, LJ
    HAGEMEISTER, FB
    MCLAUGHLIN, P
    CABANILLAS, F
    SPITZER, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) : 179 - 185
  • [69] JENSEN BV, 1990, EUR J HAEMATOL, V44, P165
  • [70] THE SIGNIFICANCE OF THE RESIDUAL MEDIASTINAL MASS IN TREATED HODGKINS-DISEASE
    JOCHELSON, M
    MAUCH, P
    BALIKIAN, J
    ROSENTHAL, D
    CANELLOS, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) : 637 - 640
234567891011